Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Mohd Haider

What's Driving bioAffinity Technologies' Big Pre-Market Surge?

Financial,Market,Data,Stock,green,Stock,Market,Growth,Background,Illustration,green,Candlestick

bioAffinity Technologies Inc. (NASDAQ:BIAF) saw its stock climb to $2.96 during pre-market trading on Wednesday, marking a 20.82% jump from its previous close. The surge came after the company released its third-quarter sales update.

Check out the current price of BIAF stock here

Third Quarter Sales Performance

The Texas-based company announced on Tuesday that sales of its CyPath® Lung diagnostic test reached a record high in the third quarter, marking a 95% increase from the previous quarter. For the first nine months of 2025, sales rose 97% compared to the same period last year.

Test Specifications

The test uses advanced technology to examine mucus from patients' lungs. Clinical studies have shown it achieves 92% sensitivity, 87% specificity, and 88% accuracy in detecting lung cancer in high-risk patients with lung nodules smaller than 20 millimeters.

See Also: Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?

Market Expansion and Adoption

The increase reflects broader use of CyPath® Lung by Veterans’ hospitals and continued market growth in the mid-Atlantic region, the company said.

Third-quarter results also showed a 77% rise in new patients using CyPath® Lung, along with higher compliance in collecting and returning at-home samples.

Stock Performance

bioAffinity has dropped sharply over the past year, losing 95.33%, and has fallen 85.98% in the last six months. Its price has ranged between $2.34 and $67.12 during this time.

The biotech’s market capitalization stands at $7.11 million, with an average daily trading volume of 3.85 million shares.

Price Action: According to Benzinga Pro, BIAF closed Tuesday's regular trading session at $2.45, up 4.3%.

Benzinga Edge Stock Rankings indicate that bioAffinity Technologies has a negative price trend across all time frames. Track the performance of other players in this segment.

Read Next:

Photo courtesy: jira pliankharom on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.